Health Condition 1: Q249- Congenital malformation of heart,unspecified
Conditions
Interventions
None listed
Sponsors
Army Hospital Research and Referral
Eligibility
Inclusion criteria
Inclusion criteria: All consecutive patients who will undergo cardiac surgery for congenital heart disease and in whom the Decellularized Bovine pericardium (Synkroscaff) membrane will be used.
Exclusion criteria
Exclusion criteria: 1.Patients in whom other prosthetic material will be used. 2.Patients who had cardiac interventions done pre operatively like attempted ASD, VSD device closures, balloon valvotomy procedures prior to surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| On echocardiography the following parameters will be evaluated for presence or absence of calcification, aneurysmal dilatation, leakages/tears, infective endocarditis, stenosis. (as per proforma) Timepoint: Outcome variables: The primary outcome variables will be noted on echocardiography. The incidence of calcification, aneurysmal dilatation around prosthesis, leakages/tears will be observed at regular intervals as follows In the immediate postoperative echocardiography At the time of discharge At 1 month post-operatively At 3 month post-operatively 6 month post-operatively And at 1 year post-operatively. | — |
Secondary
| Measure | Time frame |
|---|---|
| LeakageTimepoint: 1 year | — |
Countries
India
Contacts
Public ContactNikhil Tiwari
Army Hospital Research and Referral
Outcome results
None listed